Vitamin D Blood Levels: How to Read Your 25(OH)D Result

A vitamin D blood level looks simple — one number, one reference range — until you discover that the range depends on which authority your lab follows. Vitamin D blood levels are the most argued-over numbers in nutrition, and this page does the one thing that resolves most of the confusion: it puts the NIH and Endocrine Society frameworks side by side, each labelled with its source, so you can see exactly where they agree and where they were never going to.

Once you know where your number sits, vitamin D dosage covers what intakes correspond to each zone, and the combined routine is in vitamin D3 with K2.

What does the test actually measure?

The test measures serum 25-hydroxyvitamin D, written 25(OH)D. This is the storage form produced in the liver from both vitamin D2 and D3, from sun, food and supplements combined. It is the accepted status marker because it reflects total input and lasts weeks in circulation. It is not the active hormone — that is 1,25-dihydroxyvitamin D (calcitriol), which the kidneys make on demand and which stays tightly regulated even when stores are low. If your report says calcitriol, you were given a different test for a different (usually kidney or parathyroid) question.

Two practical notes before the ranges. Assays vary: the NIH and the literature both acknowledge that different lab methods can return noticeably different numbers on the same blood, which is why standardisation programmes exist and why a small change between two tests from different labs may be noise, not biology. And season matters: a level drawn in late winter in a northern country is your annual low point; the same habits in September would read higher.

How do the NIH and Endocrine Society ranges compare?

25(OH)D level	NIH / National Academy framework	Endocrine Society 2011 framework
Below 30 nmol/L (12 ng/mL)	Risk of deficiency	Deficiency
30 to below 50 nmol/L (12–20 ng/mL)	Potentially inadequate for some people	Deficiency (below 20 ng/mL)
50 to below 75 nmol/L (20–30 ng/mL)	Adequate for nearly all healthy people	Insufficiency (21–29 ng/mL)
75 nmol/L (30 ng/mL) and above	Adequate; no added benefit shown	Sufficiency
Above 125 nmol/L (50 ng/mL)	May be linked to adverse effects	Upper end of its preferred range discussions
Above 375 nmol/L (150 ng/mL)	Toxicity range — hypercalcemia risk	Toxicity range

Read the table by zone, because the zones tell the real story:

• Below 30 nmol/L (12 ng/mL): both frameworks effectively agree this is deficiency territory, where bone softening (osteomalacia in adults, rickets in children) becomes a risk. This needs medical correction, not just a gentle supplement.
• 30–50 nmol/L (12–20 ng/mL): the NIH calls this potentially inadequate; the 2011 Endocrine Society guideline called everything under 20 ng/mL deficient. Same blood, two labels. Treatment decisions here depend on your situation — bone health, age, fall risk, other conditions — not on winning the labelling argument.
• 50–75 nmol/L (20–30 ng/mL): adequate per NIH; “insufficient” per the old Society cut-off. This band is where most of the internet’s vitamin D anxiety lives. The NIH position — set from the totality of bone-health evidence — is that nearly everyone’s needs are met here.
• At or above 75 nmol/L (30 ng/mL): sufficient by both historical frameworks. Nothing above this has proven extra benefit for healthy adults.
• Above 125 nmol/L (50 ng/mL): the NIH flags possible adverse associations. Above 375 nmol/L (150 ng/mL), toxicity with high blood calcium is the documented risk.

The update that matters: in its 2024 guideline, the Endocrine Society no longer endorses specific 25(OH)D levels to define sufficiency, insufficiency or deficiency for healthy adults, because trials have not tied distinct thresholds to distinct outcomes. It also recommends against routine 25(OH)D testing in healthy adults. We present the 2011 ranges because many clinicians and labs still use them — labelled as the 2011 framework, not as current Society doctrine.

Who should actually get tested?

Both the NIH evidence summaries and the 2024 Endocrine Society guideline land in a similar place: routine population screening of healthy adults is not recommended, because treating numbers in people without risk factors has not shown outcome benefits. Testing earns its cost when the result would change management:

• Symptoms or signs compatible with deficiency, such as bone pain or proximal muscle weakness, or diagnosed low bone density.
• Risk factors stacking up: malabsorption (coeliac disease, inflammatory bowel disease, bariatric surgery), kidney or liver disease, medications that alter vitamin D metabolism such as certain anticonvulsants or corticosteroids.
• Darker skin combined with northern latitude and low sun exposure, or consistently covered skin.
• You are supplementing above the RDA long-term and want confirmation you are not overshooting.
• A clinician is deciding whether a deficiency-correction course is needed and, later, whether it worked.

If none of that applies, the guideline-backed move is unglamorous: meet the RDA (600 IU to age 70, 800 IU after, per vitamin D dosage) through diet, sensible sun and a modest supplement if your exposure is poor. UK readers should note the NHS frames its own advice around the 10-microgram supplement recommendation rather than routine testing; see vitamin D3 with K2 (UK).

What should you do with your number?

A sane sequence, whichever framework your lab used:

1. Convert the unit first. nmol/L divided by 2.5 equals ng/mL. Half of all “my level crashed” panics are unit changes between labs.
2. Place it in both frameworks. If it is adequate for the NIH, a stricter label from an older guideline is not an emergency.
3. Match the response to the zone. Deficiency-range results go to a clinician for a correction plan. Grey-zone results usually mean meeting at least the RDA consistently, taken with food — see when to take vitamin D — and rechecking in a few months if your clinician wants confirmation. High results mean auditing every supplement, multivitamin and fortified product for total dose.
4. Retest at the right interval. Levels take roughly 2–3 months to stabilise after an intake change. Testing at three weeks measures the climb, not the destination.

What else moves your result besides supplements?

Several ordinary factors shift 25(OH)D enough to matter when you compare two results. Body weight: vitamin D is fat-soluble and distributes into body fat, so people with obesity tend to show lower serum levels at the same intake — one reason clinicians sometimes use higher intakes in that group. Season and latitude: a result drawn in February at a northern latitude reflects months of negligible skin synthesis; the same habits produce a higher number in September. Recent sun holidays can lift a result for weeks, masking your usual status. Assay differences: methods vary between laboratories despite standardisation efforts, so a 10 nmol/L change between two different labs may be measurement noise rather than a real change. Illness and inflammation can temporarily depress measured levels. None of this makes testing useless — it makes single numbers provisional. Trends on the same assay, interpreted with the season noted, are the meaningful unit. If a result surprises you in either direction, repeating it before redesigning your dose is usually wiser than reacting to one draw.

Should you pay for a home vitamin D test?

Finger-prick home kits now return a 25(OH)D number without a clinic visit, and for a generally healthy adult who simply wants a baseline they are a reasonable tool — the better kits use laboratory methods aligned with the same standardisation programmes as hospital assays. Their limits are practical: sample collection errors widen the margin around the result, and a number without clinical context invites exactly the over-reaction this page warns against. Treat a home result the way you would treat a home blood-pressure reading: useful for spotting the clearly low and the clearly high, a prompt for a proper clinical test when it lands somewhere that would change what you take, and never the sole basis for a high-dose correction course.

Who should not take this — interpreting levels without a clinician?

This page’s safety section is about a different kind of harm: self-treatment based on a number.

• Do not self-prescribe correction doses (such as 50,000 IU weekly) from a lab printout. Those regimens exist, are sometimes appropriate, and are medical treatment with follow-up — especially in malabsorption, where both the dose and the form differ.
• Do not chase levels above 75 nmol/L (30 ng/mL). No authority shows added benefit for healthy adults, and the NIH flags possible harm above 125 nmol/L. A higher number is not a higher grade.
• People with kidney disease, parathyroid disorders, sarcoidosis or a history of high calcium or kidney stones should interpret any level with their specialist: their safe range and their treatment thresholds are different from the general-population table above.
• People taking thiazide diuretics, digoxin, corticosteroids or high-dose calcium should discuss results and any dose change with their prescriber, because vitamin D, calcium and these medicines interact.
• Pregnancy: discuss results with your maternity clinician; the reference intakes (600 IU RDA, 4,000 IU UL) still frame what is appropriate, and self-escalation is not.
• Children’s results use paediatric reference frameworks and paediatric clinicians — adult cut-off arguments do not transfer.

Talk to your doctor or pharmacist if your result sits in a deficiency or high zone, or if any of the situations above apply. A number is information; what to do about it is a clinical judgement.